IBRX
ImmunityBio (IBRX) Business Model
Review ImmunityBio (IBRX) business model with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Sector
- Healthcare
- Industry
- Biotechnology
- Annual revenue
- $113.29M
ImmunityBio (IBRX) Business Model research
ImmunityBio operates in the Biotechnology industry within the Healthcare sector. Review how the company generates revenue, the customers it serves and the resources required to sustain growth.
A durable business model should be evaluated through revenue quality, margins, cash conversion, competitive positioning and capital requirements. The financials and competitors sections provide the next steps for that assessment.